A new class of anti-filariasis compounds: a preliminary look.
Parasitic nematode worms which produce filariasis in humans place approximately one billion people at risk in more than 75 countries. More than 100 million people are infected with these diseases and are recognized as being of significant military importance. During World War II, filariasis was among the leading causes of medical evacuation from the entire South Pacific area. Agents available to treat the diseases exhibit significant toxicity. Better drugs are urgently needed. Data are reported from work using a Mongolian jird animal model on a new class of potential drugs, thiosemicarbazones. These compounds exhibit activity against the parasites which cause both lymphatic filariasis and the "onchocerciasis type" of the disease.
Kinnamon
K E
KE
School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799, USA.
Engle
R R
RR
Poon
B T
BT
McCall
J W
JW
Dzimianski
M T
MT
D000818:Animals; D017179:Brugia pahangi / Q000187:drug effects*; D006224:Cricetinae; D004153:Dipetalonema / Q000187:drug effects*; D004195:Disease Models, Animal; D004285:Dogs; D005368:Filariasis / Q000188:drug therapy / Q000453:epidemiology; D005369:Filaricides / Q000737:chemistry / Q000494:pharmacology*; D005849:Gerbillinae
D005369:Filaricides